Karen Albrecht

Karen Albrecht is a seasoned project portfolio manager currently overseeing a portfolio of over 60 manufacturing science and technology projects for cell therapy at Bristol Myers Squibb. With extensive experience in project management across various biotechnology companies, including roles as associate director at Bolt Biotherapeutics, senior CMC project manager at Silverback Therapeutics, and global technical development project manager at Seagen, Karen has demonstrated expertise in delivering developmental therapies on time and within budget. Educational credentials include a Bachelor of Science in Biochemistry/Molecular Biology from the University of Wisconsin-Eau Claire and a Programmer/Analyst degree from Waukesha County Technical College.